Pharmacosmos bets on new subsidiary for product launch in USA

Changing its strategy, Holbæk-based Pharmacosmos has chosen to go independent for the launch of Monoferric in the USA. A new subsidiary company led by a Dane will run the launch.

Photo: Pharmacosmos/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles